| Name | IDO-IN-6 |
|---|---|
| Synonyms |
5H-Imidazo[5,1-a]isoindole-5-ethanol, 6-fluoro-α-(trans-4-hydroxycyclohexyl)-, (αS,5S)-
trans-4-{(1S)-2-[(5S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexanol |
| Description | IDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC50 of <1 μM. |
|---|---|
| Related Catalog | |
| Target |
IDO:1 μM (IC50) |
| In Vitro | IDO-IN-6 (Compound 1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC50 of <1 μM (this is the concentration of IDO-IN-6 at which inhibits 50% of enzymatic activity using recombinant human IDO)[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 555.4±35.0 °C at 760 mmHg |
| Molecular Formula | C18H21FN2O2 |
| Molecular Weight | 316.370 |
| Flash Point | 289.7±25.9 °C |
| Exact Mass | 316.158691 |
| LogP | 1.28 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.683 |
| Storage condition | 2-8℃ |